Prabhakar M. Dongre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Prabhakar M. Dongre has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Dushyant C. Kothari
University of Mumbai
5 shared publications - Abhijeet Bhogale
Department of Physics, University of Mumbai, Vidyanagari, Santacruz, Mumbai 400 098, India
3 shared publications - Antonio Miotello
Department of Physics, University of Trento, Via Sommarive 14, 38123 Trento, Italy
3 shared publications J. Mariam
Department of Biophysics, University of Mumbai, Vidyanagari, Santacruz, Mumbai 400 098, India
3 shared publicationsJessy Mariam
A Department of Biophysics , University of Mumbai , Vidyanagari, Santacruz (E), Mumbai 400098 , India
3 shared publications- Nainesh Patel
Department of Physics and Electronics, Christ University, Bengaluru, India
3 shared publications
Latest Publications
- 27 September 2023
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 305, 123469
Biophysical study of DC electric field induced stable formation of albumin-gold nanoparticles corona and curcumin binding
- 27 September 2023
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 305, 123469
Biophysical study of DC electric field induced stable formation of albumin-gold nanoparticles corona and curcumin binding
- 20 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 231, 123368
Biophysical study of cisplatin loaded albumin-gold nanoparticle and its interaction with glycans of gp60 receptor
- 20 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 231, 123368
Biophysical study of cisplatin loaded albumin-gold nanoparticle and its interaction with glycans of gp60 receptor
- 1 January 2022
- Published by Indian Pharmaceutical Association - IPA in Indian Journal of Pharmaceutical Sciences
- Vol. 84 (4) , 938-949
Inhibition of Russell’s Viper Venom using Silver Nanoparticle-Bovine Serum Albumin-Curcumin Conjugates
- 1 January 2022
- Published by Indian Pharmaceutical Association - IPA in Indian Journal of Pharmaceutical Sciences
- Vol. 84 (4) , 938-949
Inhibition of Russell’s Viper Venom using Silver Nanoparticle-Bovine Serum Albumin-Curcumin Conjugates
- 21 May 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (19) , 9253-9269
BSA-drug-ZnO-PEI conjugates interaction with glycans of gp60 endothelial cell receptor protein for targeted drug delivery: a comprehensive spectroscopic study
The zinc oxide (ZnO) nanoparticles (NPs) have several biomedical applications such as drug delivery, bio-imaging, and biomedical research. ZnO NPs were remedied with polyethyleneimine (PEI) and modified with bovine serum albumin (BSA). Two anticancer drugs - Cisplatin (CIS) and Gemcitabine (GEM) were used in conjugation with BSA. BSA-ZnO-PEI (conjugate 1), BSA-CIS-ZnO-PEI (conjugate 2), and BSA-GEM-ZnO-PEI (conjugate 3) can be used for targeted drug delivery via glycans - N-acetylneuraminic acid (NANA), L-fucose (FUC), N-acetyl glucosamine (NAG), D-mannose (MAN), and D-galactose (GAL), of albumin binding membrane receptor protein (gp60). Considerable interaction and the strong binding of conjugate 2 and conjugate 3 with NANA were observed by UV-visible absorption and fluorescence spectra. The electrostatic stability of conjugate 2 and conjugate 3 with NANA was considerably increased in comparison to conjugate 1 as evident with zeta potential values. The fluorescence quenching data (Ksv and kq) and binding parameters (K and n) of BSA-CIS, BSA-GEM, conjugate 2, and conjugate 3 with NANA and FUC attributes to the strong binding. Amide I and amide III bands of the Raman signal suggested insignificant loss in alpha-helical and beta-sheet content of conjugate 2 and conjugate 3 with NANA and FUC. Therefore, the present study is going to assist in the comprehensive development of conjugates for targeted drug delivery based on the differential glycation pattern of gp60 protein. Communicated by Ramaswamy H. Sarma
- 21 May 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (19) , 9253-9269
BSA-drug-ZnO-PEI conjugates interaction with glycans of gp60 endothelial cell receptor protein for targeted drug delivery: a comprehensive spectroscopic study
The zinc oxide (ZnO) nanoparticles (NPs) have several biomedical applications such as drug delivery, bio-imaging, and biomedical research. ZnO NPs were remedied with polyethyleneimine (PEI) and modified with bovine serum albumin (BSA). Two anticancer drugs - Cisplatin (CIS) and Gemcitabine (GEM) were used in conjugation with BSA. BSA-ZnO-PEI (conjugate 1), BSA-CIS-ZnO-PEI (conjugate 2), and BSA-GEM-ZnO-PEI (conjugate 3) can be used for targeted drug delivery via glycans - N-acetylneuraminic acid (NANA), L-fucose (FUC), N-acetyl glucosamine (NAG), D-mannose (MAN), and D-galactose (GAL), of albumin binding membrane receptor protein (gp60). Considerable interaction and the strong binding of conjugate 2 and conjugate 3 with NANA were observed by UV-visible absorption and fluorescence spectra. The electrostatic stability of conjugate 2 and conjugate 3 with NANA was considerably increased in comparison to conjugate 1 as evident with zeta potential values. The fluorescence quenching data (Ksv and kq) and binding parameters (K and n) of BSA-CIS, BSA-GEM, conjugate 2, and conjugate 3 with NANA and FUC attributes to the strong binding. Amide I and amide III bands of the Raman signal suggested insignificant loss in alpha-helical and beta-sheet content of conjugate 2 and conjugate 3 with NANA and FUC. Therefore, the present study is going to assist in the comprehensive development of conjugates for targeted drug delivery based on the differential glycation pattern of gp60 protein. Communicated by Ramaswamy H. Sarma
- 29 January 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (13) , 6193-6210
β-Lactoglobulin-gold nanoparticles interface and its interaction with some anticancer drugs – an approach for targeted drug delivery
The protein-nanoparticle interface plays a crucial role in drug binding and stability, in turn enhancing efficacy in targeted drug delivery. In the present study, whey protein β-lactoglobulin (BLG) is conjugated with gold nanoparticles (AuNP) and its interaction with curcumin (CUR) and gemcitabine (GEM) has been explored. Further, AuNP-BLG conjugate interactions with anticancer drugs were characterized using dynamic light scattering (DLS), zeta potential, UV-visible, Raman spectroscopy, fluorescence, circular dichroism along with molecular dynamics simulation. The cytotoxicity studies were performed using breast cancer cell lines (MCF-7). ∼8 µM of BLG resides on AuNP (∼29 nm) surface revealed by DLS. Raman scattering of AuNP-BLG conjugate showed orientation of the central calyx of BLG towards solvent. BLG fluorescence confirmed the interaction between AuNP-BLG conjugate with drugs and indicated strong binding and affinity (for CUR KD = 3.71 x 108 M −1, n = 1.83, and for GEM KD = 3.78 x 103 M −1, n = 0.94), enhanced in the presence of AuNP. CD and Raman analysis exhibited selective hydrophilic and hydrophobic conformations induced by drug binding. Computational studies on BLG-drug complexes revealed that the residues Pro38, Leu39 and Met107 are largely associated with CUR binding, while GEM interaction is via hydrophilic contacts which significantly matches with spectroscopic investigation. IC50 values were calculated for all components of this loading system on MCF-7. The possible mechanisms of interaction between AuNP-BLG with anticancer drugs has been explored at the molecular level. We believe that these conjugates could be considered in the targeted drug delivery studies for cancer research. Communicated by Ramaswamy H. Sarma
- 29 January 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (13) , 6193-6210
β-Lactoglobulin-gold nanoparticles interface and its interaction with some anticancer drugs – an approach for targeted drug delivery
The protein-nanoparticle interface plays a crucial role in drug binding and stability, in turn enhancing efficacy in targeted drug delivery. In the present study, whey protein β-lactoglobulin (BLG) is conjugated with gold nanoparticles (AuNP) and its interaction with curcumin (CUR) and gemcitabine (GEM) has been explored. Further, AuNP-BLG conjugate interactions with anticancer drugs were characterized using dynamic light scattering (DLS), zeta potential, UV-visible, Raman spectroscopy, fluorescence, circular dichroism along with molecular dynamics simulation. The cytotoxicity studies were performed using breast cancer cell lines (MCF-7). ∼8 µM of BLG resides on AuNP (∼29 nm) surface revealed by DLS. Raman scattering of AuNP-BLG conjugate showed orientation of the central calyx of BLG towards solvent. BLG fluorescence confirmed the interaction between AuNP-BLG conjugate with drugs and indicated strong binding and affinity (for CUR KD = 3.71 x 108 M −1, n = 1.83, and for GEM KD = 3.78 x 103 M −1, n = 0.94), enhanced in the presence of AuNP. CD and Raman analysis exhibited selective hydrophilic and hydrophobic conformations induced by drug binding. Computational studies on BLG-drug complexes revealed that the residues Pro38, Leu39 and Met107 are largely associated with CUR binding, while GEM interaction is via hydrophilic contacts which significantly matches with spectroscopic investigation. IC50 values were calculated for all components of this loading system on MCF-7. The possible mechanisms of interaction between AuNP-BLG with anticancer drugs has been explored at the molecular level. We believe that these conjugates could be considered in the targeted drug delivery studies for cancer research. Communicated by Ramaswamy H. Sarma
- 13 February 2020
- Published by Wiley in ChemistrySelect
- Vol. 5 (6) , 2035-2049
Functionalized Alpha‐lactalbumin Conjugated with Gold Nanoparticle for Targeted Drug Delivery
The protein‐nanoparticles conjugate has been developed as a targeted drug delivery system which selectively and preferentially delivers the therapeutic agents. Here, the alpha‐lactalbumin (ALA) was purified by size exclusion chromatography and confirmed by gel electrophoresis and mass spectrometry (MS). Functionalization of gold nanoparticles (AuNP, ∼29 nm) with ALA was optimized by light scattering and zeta potential measurements. The nanoconjugates (AuNP‐ALA) and ALA showed strong binding and affinity with curcumin and gemcitabine studied using biophysical analysis. The presence of native form of curcumin with ALA was investigated by MS. 8‐anilino‐1‐naphthalenesulfonic acid binding assay showed 95 % surface hydrophilicity of ALA. Circular dichroism and Fourier transform infrared spectroscopy analysis shows increased alpha‐helicity due to the binding of drugs, revealed large increase in non‐covalent interaction. Vesicular membrane interaction with ALA and nanoconjugate exhibited strong interaction at the vesicles surface. The alpha‐lactalbumin‐nanoparticle conjugate in combination with drugs, could be exploited to establish a targeted drug delivery system.
- 13 February 2020
- Published by Wiley in ChemistrySelect
- Vol. 5 (6) , 2035-2049
Functionalized Alpha‐lactalbumin Conjugated with Gold Nanoparticle for Targeted Drug Delivery
The protein‐nanoparticles conjugate has been developed as a targeted drug delivery system which selectively and preferentially delivers the therapeutic agents. Here, the alpha‐lactalbumin (ALA) was purified by size exclusion chromatography and confirmed by gel electrophoresis and mass spectrometry (MS). Functionalization of gold nanoparticles (AuNP, ∼29 nm) with ALA was optimized by light scattering and zeta potential measurements. The nanoconjugates (AuNP‐ALA) and ALA showed strong binding and affinity with curcumin and gemcitabine studied using biophysical analysis. The presence of native form of curcumin with ALA was investigated by MS. 8‐anilino‐1‐naphthalenesulfonic acid binding assay showed 95 % surface hydrophilicity of ALA. Circular dichroism and Fourier transform infrared spectroscopy analysis shows increased alpha‐helicity due to the binding of drugs, revealed large increase in non‐covalent interaction. Vesicular membrane interaction with ALA and nanoconjugate exhibited strong interaction at the vesicles surface. The alpha‐lactalbumin‐nanoparticle conjugate in combination with drugs, could be exploited to establish a targeted drug delivery system.
- 1 April 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 126, 74-90
Albumin nanoparticles conjugates binding with glycan - A strategic approach for targeted drug delivery
- 1 April 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 126, 74-90
Albumin nanoparticles conjugates binding with glycan - A strategic approach for targeted drug delivery
- 15 June 2018
- Published by Wiley in European Journal of Oral Sciences
- Vol. 126 (4) , 251-262
Alterations in desmosomal adhesion at protein and ultrastructure levels during the sequential progressive grades of human oral tumorigenesis
With the aim of developing early diagnostic/prognostic markers for oral cancer, desmosomal adhesion in sequentially progressive grades of tissues from oral normal/disorders (normal, hyperplastic, dysplastic, non‐metastatic/metastatic tumours, and metastatic nodes) was investigated at protein and ultrastructural levels using immunohistochemistry and transmission electron microscopy, respectively. The expression of desmosomal proteins was higher in hyperplastic tissues than in normal tissues but was significantly decreased in subsequent progressive stages of the disease. Altered expression of desmosomal proteins was significantly correlated with local recurrence and disease‐free survival. Ultrastructural analysis in the corresponding tissues revealed cytoplasmic clustering of desmosomes in hyperplasia; in more advanced disease stages, a significantly lower number of desmosomes and widened intercellular spaces were observed. Altered protein expression resulting in structural changes was confirmed by knocking down desmoplakin expression in non‐transformed cells, which failed to form normal desmosome structures and induced a cell‐transformation phenotype. Our data suggest that alterations in desmosomal assembly initiate at an early hyperplastic grade and, with more advanced disease stages, the severity of the alterations gradually becomes higher. Alterations in desmosomal adhesion can be useful for early detection of high‐risk premalignant lesions, as well as for identification of invasive characteristics of primary non‐metastatic tumours. Early detection will help to control further progression of disease by timely intervention.
- 15 June 2018
- Published by Wiley in European Journal of Oral Sciences
- Vol. 126 (4) , 251-262
Alterations in desmosomal adhesion at protein and ultrastructure levels during the sequential progressive grades of human oral tumorigenesis
With the aim of developing early diagnostic/prognostic markers for oral cancer, desmosomal adhesion in sequentially progressive grades of tissues from oral normal/disorders (normal, hyperplastic, dysplastic, non‐metastatic/metastatic tumours, and metastatic nodes) was investigated at protein and ultrastructural levels using immunohistochemistry and transmission electron microscopy, respectively. The expression of desmosomal proteins was higher in hyperplastic tissues than in normal tissues but was significantly decreased in subsequent progressive stages of the disease. Altered expression of desmosomal proteins was significantly correlated with local recurrence and disease‐free survival. Ultrastructural analysis in the corresponding tissues revealed cytoplasmic clustering of desmosomes in hyperplasia; in more advanced disease stages, a significantly lower number of desmosomes and widened intercellular spaces were observed. Altered protein expression resulting in structural changes was confirmed by knocking down desmoplakin expression in non‐transformed cells, which failed to form normal desmosome structures and induced a cell‐transformation phenotype. Our data suggest that alterations in desmosomal assembly initiate at an early hyperplastic grade and, with more advanced disease stages, the severity of the alterations gradually becomes higher. Alterations in desmosomal adhesion can be useful for early detection of high‐risk premalignant lesions, as well as for identification of invasive characteristics of primary non‐metastatic tumours. Early detection will help to control further progression of disease by timely intervention.
- Open Access
- 1 January 2018
- Published by Biophysical Society of Japan in Biophysics and Physicobiology
- Vol. 15, 204-213
Inhibition of crude viper venom action by silver nanoparticles: A biophysical and biochemical study
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2018
- Published by Biophysical Society of Japan in Biophysics and Physicobiology
- Vol. 15, 204-213
Open AccessInhibition of crude viper venom action by silver nanoparticles: A biophysical and biochemical study
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies